Susana De Sola
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effectiveness of a psychotherapeutic intervention group program in the improvement of caregiver well-being in Alzheimer's disease patients' family caregivers: the CuiDem study
Journal: Revista de neurologia
Published: October 11, 2022
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: November 06, 2018
Anomalous White Matter Structure and the Effect of Age in Down Syndrome Patients.
Journal: Journal of Alzheimer's disease : JAD
Published: February 23, 2017
VNTR-DAT1 and COMTVal158Met Genotypes Modulate Mental Flexibility and Adaptive Behavior Skills in Down Syndrome.
Journal: Frontiers in behavioral neuroscience
Published: May 19, 2016
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
Journal: The Lancet. Neurology
Published: December 25, 2015
Assessment of Cognitive Scales to Examine Memory, Executive Function and Language in Individuals with Down Syndrome: Implications of a 6-month Observational Study.
Journal: Frontiers in behavioral neuroscience
Published: July 24, 2015
Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Aβ42 Concentrations in Down Syndrome Young Adults.
Journal: Frontiers in behavioral neuroscience
Published: May 27, 2015
A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials.
Journal: Frontiers in psychology
Published: November 14, 2014
Anomalous brain functional connectivity contributing to poor adaptive behavior in Down syndrome.
Journal: Cortex; a journal devoted to the study of the nervous system and behavior
Published: June 02, 2014
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.
Journal: Molecular nutrition & food research
Published: May 03, 2013
The comparison of cognitive and functional performance in children and Alzheimer's disease supports the retrogenesis model.
Journal: Journal of Alzheimer's disease : JAD
Published: September 06, 2012
Neuropsychology of Alzheimer's disease.
Journal: Archives of medical research
Published: August 24, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026